newsfilter
← Latest News
PR Newswire·

PDL BioPharma Announces Private Exchange of Approximately $86.1 Million of Convertible Notes Due 2024

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that it has entered into separate privately negotiated transactions to...